Searched for
ZYDUS CADILA VACCINE
Covaxin likely to be only Covid vaccine available for children of 15-18 yrs, for nowZydus Cadila's vaccine ZyCoV-D has not yet been introduced in the country's inoculation programme, even for adults, though it had received ...
Zydus Cadila's shot to be soon part of vaccine driveTo begin with, seven states including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal will use the vaccine.
Vaccine company’s plan to cut output won't hit supply, says top govt officialAccording to the health ministry more than 139 crore vaccine doses have been provided to states and UTs so far through the central governme...
Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...
Vaccination of children not likely to happen anytime soon: Health minister MandaviyaThe health minister refused to comment on whether vaccination could be allowed in January next year. "I cannot say when. But not right now,...
Private hospitals begin talks with schools for kids' vaccinationThe government is expected to come out with guidelines for vaccinating children next week.
Vaccinations for healthy kids likely to start early next yearGovernment data shows that for children, hospitalisation in case of Covid 19 was extremely uncommon. It was also seen that children were mo...
Right pricing to hold the key for Zydus Cadila's vaccine launchZydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...
Govt expert panel recommends emergency use authorisation for Covaxin in 2 to 18 age group“Here the safety follow-up is longer. So, what we have done is that we have presented interim data. The trial design is such that one month...
SEC set to review Covaxin trial data for use in childrenBharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age.
Children with comorbidities between ages 12 and 17 may get vaccine by October-NovemberThe government is planning to get children with comorbidities the vaccine by October or November. Children between the ages of 12 and 17, w...
Covaxin supply set to rise as new plant goes on streamThe Ankleshwar plant, constructed in 2020, has a manufacturing capacity of more than 10 million doses per month, and supplies will be avail...
Reliance Life gets regulatory nod for trials of 2-dose vaccineThe drug regulatory authority on Thursday approved Reliance Life Sciences, part of India's largest private sector enterprise-application, s...
NTAGI to soon chalk out roadmap to introduce Zydus Cadila's vaccine in Covid inoculation driveThe indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received Emergency Use Authorisation from the drug ...
Covid-19: Government hopeful of vaccine for 12+ kids soonNiti Aayog member (health) Dr VK Paul said, “We have visibility of 15 crore (150 million) doses for August. We will bring you the exact num...
Zydus Cadila's vaccine for kids above 12 to come up for approval this weekThe drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...
India likely to have COVID vaccine for children above 2 years by September-October: AIIMS DirectorIn an interview with ANI, Dr Guleria said that Covaxin's data for children after completion of phase two or three trials is expected by Sep...
Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in MexicoIn June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Des...
India seems to be getting closer to an antidote, even as the coronavirus situation worsensThis week India overtook the US in daily addition of new COVID-19 cases. It is worrying. The World Health Organization says that the infect...
No compromise on rigorous evaluation for vaccine candidates: Scientific Advisor VijayRaghavanPhase 1 of the human trial of any vaccine usually takes 28 days and that is followed by two other phases, VijayRaghavan said while addressi...